中医药/天然药在HR阳性乳腺癌中的作用机制综述
本文综述了中医药/天然药单体及复方通过PI3K/AKT、JAK2/STAT3、MAPK、Wnt等信号通路调控相关基因与蛋白表达,抑制HR阳性乳腺癌增殖转移、与内分泌药协同并逆转内分泌耐药。检索PubMed、Web of Science及CNKI建库至2023年7月。
要点
- 中医药/天然药可通过多条信号通路抑制HR阳性乳腺癌增殖与转移。
- 与内分泌药联用可发挥协同作用并逆转内分泌耐药。
- 临床与基础实验设计仍存不足,需更深入科学探索。
核心结论
- 中医药/天然药成分多样,为乳腺癌治疗新方法研发提供更多选择与创新空间。
- 虽已取得进展,但临床与基础实验设计仍存诸多问题,需更深入科学探索。
研究设计与样本
- 本文为综述,检索PubMed、Web of Science及CNKI数据库(建库至2023年7月)。
- 检索词包括「HR-positive breast cancer」「HR + BC」与「traditional Chinese medicine」「TCM」「natural plant」「herb」等。
主要发现
- 中医药/天然药单体及复方可通过PI3K/AKT、JAK2/STAT3、MAPK、Wnt等信号通路调控相关基因与蛋白表达。
- 可抑制HR阳性乳腺癌肿瘤的增殖与转移。
- 与内分泌药物联用可发挥协同作用,并逆转内分泌耐药。
临床怎么用
- 可关注中医药/天然药与内分泌药联用以协同增效及逆转耐药的潜在价值。
- 应用时需结合具体成分与通路机制,并注意现有研究设计局限。
局限性
- 临床与基础实验设计仍存在许多问题。
- 仍需更多深入的科学探索与研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: With the emergence of endocrine resistance, the survival and good prognosis of HR-positive breast cancer (HR + BC) patients are threatened. As a common complementary and alternative therapy in cancer treatment, traditional Chinese medicine (TCM) has been widely used, and its internal mechanisms have been increasingly explored. AIM OF THE REVIEW: In this review, the development status and achievements in understanding of the mechanisms related to the anti-invasion and anti-metastasis effects of TCM against HR + BC and the reversal of endocrine drug resistance by TCM in recent years have been summarized to provide ideas for antitumour research on the active components of TCM/natural medicine. METHODS: We searched the electronic databases PubMed, Web of Science, and China National Knowledge Infrastructure database (CNKI) (from inception to July 2023) with the key words "HR-positive breast cancer" or "HR-positive breast carcinoma", "HR + BC" and "traditional Chinese medicine", "TCM", or "natural plant", "herb", etc., with the aim of elucidating the intrinsic mechanisms of traditional Chinese medicine and natural medicine in the treatment of HR + BC. RESULTS: TCM/natural medicine monomers and formulas can regulate the expression of related genes and proteins through the PI3K/AKT, JAK2/STAT3, MAPK, Wnt and other signalling pathways, inhibit the proliferation and metastasis of HR + BC tumours, play a synergistic role in combination with endocrine drugs, and reverse endocrine drug resistance. CONCLUSION: The wide variety of TCM/natural medicine components makes the research and development of new methods of TCM for BC treatments more selective and innovative. Although progress has been made on research on TCM/natural medicine, there are still many problems in clinical and basic experimental designs, and more in-depth scientific explorations and research are still needed.
引用
- Yu Q, Xu C, Song J, et al. Mechanisms of Traditional Chinese medicine/natural medicine in HR-positive Breast Cancer: A comprehensive Literature Review. J Ethnopharmacol. 2023. PMID: 37866466. doi:10.1016/j.jep.2023.117322
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。